Safety/Quality

Latest Issue of OR Manager
February 2020
Home Safety/Quality

Boston Scientific receives FDA clearance for single-use duodenoscope

Editor's Note Boston Scientific announced December 13 that it had received Food & Drug Administration (FDA) 510(k) clearance for the EXALT Model D Single-Use Duodenoscope for use in endoscopic retrograde cholangiopancreatography (ERCP) procedures. The EXALT Model D, which was granted Breakthrough Device Designation from the FDA, eliminates the need for…

Read More

By: Judy Mathias
December 17, 2019
Share

CMS expects greater scrutiny from Joint Commission surveyors

The start of a new year includes OR Manager’s annual updates on Joint Commission standards—an effort to help OR leaders ensure their facilities are in compliance. With increasingly stringent expectations from the Centers for Medicare & Medicaid Services (CMS), the Joint Commission and other accreditation organizations are under pressure to…

Read More

By: OR Manager
December 17, 2019
Share

Is your staff ready to manage malignant hyperthermia?

Malignant hyperthermia (MH) is a rare but life-threatening surgical complication that seems to turn the effects of general anesthesia upside down. Instead of relaxing, muscles become rigid, releasing large amounts of acid and potassium into the blood. Instead of a normal slowing of breathing, respirations quicken, and end-tidal CO2 rises.…

Read More

By: OR Manager
December 17, 2019
Share

Sponsored Message

Editorial

Projections for healthcare industry trends in 2020 started to proliferate near the end of 2019 as attention turned to the new year. Reflecting on the Institute of Medicine’s (IOM) landmark 1999 report, “To Err Is Human: Building a Safer Health System,” some healthcare leaders said the report has raised awareness…

Read More

By: OR Manager
December 17, 2019
Share

Reinvent and reap the rewards of improved handoffs--Part 1

A care transition poses a danger point for patients—failing to “hand off” needed information from one clinician to another can lead to significant morbidity and mortality. The Joint Commission was so concerned about handoffs that in 2017 it issued a sentinel event alert on the topic. “Handoffs are a safety…

Read More

By: OR Manager
December 17, 2019
Share

Well-crafted handoff tools save valuable time in OR schedule

In 2017, the Joint Commission issued a Sentinel Alert Event on the problem of inadequate handoff communication, focusing attention on this vital aspect of care. (See related story, p 22.) Clinicians and leaders agree that handoffs are important, but implementing them effectively can be challenging, particularly in the fast-paced perioperative…

Read More

By: OR Manager
December 17, 2019
Share

Sponsored Message

Providing cost-benefit analysis for ERAS-related solutions

Enhanced Recovery After Surgery The implementation of Enhanced Recovery After Surgery (ERAS) is based on the concept of organizing care around the patient, addressing medical condition needs to optimize readiness for surgery and reducing the likelihood of postoperative complications. Efficacy is measured by how well we perform according to these…

Read More

By: OR Manager
December 17, 2019
Share

To avoid penalties, know the rules for quality reporting

Keeping up with Medicare’s regulatory and reporting requirements for ambulatory surgery centers (ASCs) can be as difficult as ensuring physicians arrive to start their cases on time. “Regulations can change frequently,” says Gina Throneberry, MBA, RN, CASC, CNOR, director of education and clinical affairs for the Ambulatory Surgery Center Association…

Read More

By: OR Manager
December 17, 2019
Share

Nurses sleep less before work days than days off, affecting patient care

Editor's Note In this study from New York University Rory Meyers College of Nursing, nurses were found to sleep nearly an hour and a half less before work days than before days off, affecting patient care and safety. Using data from two surveys of 1,568 nurses collected in 2015 and…

Read More

By: Judy Mathias
December 16, 2019
Share

FDA: Medtronic recalls SynchroMed II implantable drug infusion pump

Editor's Note The Food and Drug Administration (FDA) on December 16 announced that Medtronic has recalled its SynchroMed II implantable infusion pump. The pump is being recalled because of the potential presence of foreign particles inside the pump motor assembly that may lead to a pump motor stall. Medtronic has…

Read More

By: Judy Mathias
December 16, 2019
Share

Get OR Manager Updates

Sign Up Now
OR Manager Jobs
Live chat by BoldChat